Study S000933

A Phase 1 Study to Evaluate the Pharmacokinetics of ITCA 650 in Subjects With Mild and Moderate Renal Impairment Compared to the Pharmacokinetics of Subjects With Normal Renal Function

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02320045
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 38
Start: 2014-11
Primary completion: 2015-07
Lead sponsor: Intarcia Therapeutics
Conditions: Renal Insufficiency
Interventions: DRUG:ITCA 650 (Exenatide in osmotic mini pump)
Results posted: FALSE

Registered primary outcomes

24-h Area under the Curve at steady state (AUCt,ss) [Approximately 67 Days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.